TRAW
USDTraws Pharma Inc. Common Stock
$2.200-0.150 (-6.383%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$2.350
Haut
$2.355
Bas
$2.135
Volume
0.03M
Fondamentaux de l'Entreprise
Capitalisation Boursière
15.7M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.18M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Bas $0.97Actuel $2.200Haut $19.44
Actualités Connexes
PR Newswire
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC)...
Voir plus
PR Newswire
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
Expert Systems Inc., a leading life sciences accelerator, announced its continued support for Traws Pharma (NASDAQ: TRAW) as the company initiates...
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.